Detail
| LncRNA Name | LINC00152 |
| Synonyms | CYTOR, C2orf59, LINC00152, NCRNA00152, MGC4677 |
| Region | GRCh38_2:87454781-87636740 Sequence |
| Ensembl | ENSG00000222041 |
| RefSeq | NR_024204 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | lung cancer |
| ICD-0-3 | C34 |
| Methods | qPCR, microarray etc. |
| Sample | lung cancer tissues, cell lines |
| Expression Pattern | up-regulated |
| Function Description | Our study indicates LINC00152 plays an important role in lung tumor growth and is potentially a diagnostic/prognostic marker. LINC00152 overexpression caused by histone acetylation. |
| Pubmed ID | 28592840 |
| Year | 2017 |
| Title | Overexpression of LINC00152 correlates with poor patient survival and knockdown impairs cell proliferation in lung cancer |
| External Links |
| Links for LINC00152 | GenBank HGNC lncrnadb Noncode |
| Links for lung cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.